CATX R&D to Revenue
Perspective Therapeutics Inc · R&D to Revenue
CATX R&D to Revenue
Latest reported0.00%period ending
CATX FY R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
CATX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 2,705.0894% | |
| 1,486.1227% | |
| 33.4811% | |
| 23.9185% | |
| 14.1948% | |
| 11.6322% | |
| 20.1531% | |
| 29.4783% | |
| 20.2689% | |
| 11.0719% | |
| 13.3456% | |
| 15.8516% | |
| 13.858% | |
| 14.4068% | |
| 8.8821% | |
| 6.4501% | |
| 17.6947% | |
| 18.971% | |
| 23.4429% | |
| 22.5856% | |
| 68.1759% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |